338 related articles for article (PubMed ID: 7529262)
1. Role of nitric oxide in parasympathetic modulation of beta-adrenergic myocardial contractility in normal dogs.
Hare JM; Keaney JF; Balligand JL; Loscalzo J; Smith TW; Colucci WS
J Clin Invest; 1995 Jan; 95(1):360-6. PubMed ID: 7529262
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction.
Hare JM; Loh E; Creager MA; Colucci WS
Circulation; 1995 Oct; 92(8):2198-203. PubMed ID: 7554202
[TBL] [Abstract][Full Text] [Related]
3. Lack of role for nitric oxide in cholinergic modulation of myocardial contractility in vivo.
Crystal GJ; Zhou X; Alam S; Piotrowski A; Hu G
Am J Physiol Heart Circ Physiol; 2001 Jul; 281(1):H198-206. PubMed ID: 11406486
[TBL] [Abstract][Full Text] [Related]
4. [Nitric oxide spares myocardial oxygen consumption through attenuation of contractile response to beta-adrenergic stimulation in patients with idiopathic dilated cardiomyopathy].
Shinke T; Takaoka H; Takeuchi M; Hata K; Kawai H; Okubo H; Kijima Y; Murata T; Yokoyama M
J Cardiol; 2001 Feb; 37(2):119-20. PubMed ID: 11255696
[TBL] [Abstract][Full Text] [Related]
5. Effect of vitamin C and L-NMMA on the inotropic response to dobutamine in patients with heart failure.
Mak S; Overgaard CB; Newton GE
Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2424-8. PubMed ID: 16040714
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of nitric oxide synthase augments myocardial contractile responses to beta-adrenergic stimulation.
Keaney JF; Hare JM; Balligand JL; Loscalzo J; Smith TW; Colucci WS
Am J Physiol; 1996 Dec; 271(6 Pt 2):H2646-52. PubMed ID: 8997327
[TBL] [Abstract][Full Text] [Related]
7. Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy.
Wittstein IS; Kass DA; Pak PH; Maughan WL; Fetics B; Hare JM
J Am Coll Cardiol; 2001 Aug; 38(2):429-35. PubMed ID: 11499734
[TBL] [Abstract][Full Text] [Related]
8. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system.
Balligand JL; Kelly RA; Marsden PA; Smith TW; Michel T
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):347-51. PubMed ID: 7678347
[TBL] [Abstract][Full Text] [Related]
9. Influence of nitric oxide on vascular, metabolic, and contractile responses to dobutamine in in situ canine hearts.
Crystal GJ; Zhou X; Gurevicius J; Ramez Salem M
Anesth Analg; 1998 Nov; 87(5):994-1001. PubMed ID: 9806671
[TBL] [Abstract][Full Text] [Related]
10. Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: potentiation of beta-adrenergic inotropic responsiveness.
Hare JM; Givertz MM; Creager MA; Colucci WS
Circulation; 1998 Jan; 97(2):161-6. PubMed ID: 9445168
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide formation contributes to beta-adrenergic dilation of epicardial coronary arteries in response to intravenous administration of dobutamine in dogs.
Yang H; Deng Y; Bi X; Chang Q; Bai J; Pan M; Xiang H; Liu H; Li X; Liu Y; Li C
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(2):189-91. PubMed ID: 15315177
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide spares myocardial oxygen consumption through attenuation of contractile response to beta-adrenergic stimulation in patients with idiopathic dilated cardiomyopathy.
Shinke T; Takaoka H; Takeuchi M; Hata K; Kawai H; Okubo H; Kijima Y; Murata T; Yokoyama M
Circulation; 2000 Apr; 101(16):1925-30. PubMed ID: 10779458
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of natriuretic peptides and NO on LV function in heart failure and normal dogs.
Hart CY; Hahn EL; Meyer DM; Burnett JC; Redfield MM
Am J Physiol Heart Circ Physiol; 2001 Jul; 281(1):H146-54. PubMed ID: 11406479
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide synthase inhibitor alters papillary muscle force-frequency relationship.
Finkel MS; Oddis CV; Mayer OH; Hattler BG; Simmons RL
J Pharmacol Exp Ther; 1995 Feb; 272(2):945-52. PubMed ID: 7531767
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of nitric oxide synthase slows heart rate recovery from cholinergic activation.
Sears CE; Choate JK; Paterson DJ
J Appl Physiol (1985); 1998 May; 84(5):1596-603. PubMed ID: 9572804
[TBL] [Abstract][Full Text] [Related]
16. Effects of nitric oxide synthase inhibition on myocardial capillary permeability and reactive hyperaemic response.
Hansen PR; Haunsø S
Cardiovasc Res; 1995 Jun; 29(6):862-6. PubMed ID: 7544690
[TBL] [Abstract][Full Text] [Related]
17. Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat.
Bendall JK; Damy T; Ratajczak P; Loyer X; Monceau V; Marty I; Milliez P; Robidel E; Marotte F; Samuel JL; Heymes C
Circulation; 2004 Oct; 110(16):2368-75. PubMed ID: 15466641
[TBL] [Abstract][Full Text] [Related]
18. The effects of neuropeptide Y on myocardial contractility and coronary blood flow.
Awad SJ; Einstein R; Potter EK; Richardson DP
Br J Pharmacol; 1991 Sep; 104(1):195-201. PubMed ID: 1838493
[TBL] [Abstract][Full Text] [Related]
19. NG-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs.
Kilbourn RG; Cromeens DM; Chelly FD; Griffith OW
Crit Care Med; 1994 Nov; 22(11):1835-40. PubMed ID: 7956289
[TBL] [Abstract][Full Text] [Related]
20. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.
Gauthier C; Leblais V; Kobzik L; Trochu JN; Khandoudi N; Bril A; Balligand JL; Le Marec H
J Clin Invest; 1998 Oct; 102(7):1377-84. PubMed ID: 9769330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
